Evidence map›Paper›PMID 32123164›Full record

ArticleCell death & disease2020

Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.

Giulia Petroni, Giacomo Bagni, Jessica Iorio, Claudia Duranti, Tiziano Lottini, Matteo Stefanini, Goran Kragol, Andrea Becchetti, Annarosa Arcangeli

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  10. Review
  11. The Interplay between Autophagy and Mitochondria in Cancer.International journal of molecular sciences · 2024
    Review
  12. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review.International journal of molecular sciences · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Giulia PetroniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Giacomo BagniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Jessica IorioDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Claudia DurantiDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Tiziano LottiniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Matteo StefaniniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Goran KragolFidelta Ltd., Prilaz baruna Filipovića 29, 10000, Zagreb, Croatia.
Andrea Becchetti *Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milano, Italy.
Annarosa Arcangeli *Department of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy. annarosa.arcangeli@unifi.it.
University of Florence · ITPliva (Croatia) · HRUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have studied how the macrolide antibiotic Clarithromycin (Cla) regulates autophagy, which sustains cell survival and resistance to chemotherapy in cancer. We found Cla to inhibit the growth of human colorectal cancer (CRC) cells, by modulating the autophagic flux and triggering apoptosis. The accumulation of cytosolic autophagosomes accompanied by the modulation of autophagic markers LC3-II and p62/SQSTM1, points to autophagy exhaustion. Because Cla is known to bind human Ether-à-go-go Related Gene 1 (hERG1) K

Indexed as

Antineoplastic AgentsApoptosisAutophagosomesAutophagyCell Line, TumorCell SurvivalClarithromycinColonic NeoplasmsColorectal NeoplasmsEther-A-Go-Go Potassium ChannelsHumansPhosphatidylinositol 3-KinasesSignal TransductionAntineoplastic AgentsClarithromycinEther-A-Go-Go Potassium ChannelsKCNH1 protein, humanPhosphatidylinositol 3-Kinases

Identifiers

PMID32123164
PMCPMC7052256
OpenAlexW3009247957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.